Stocks
Iovance Biotherapeutics (IOVA) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -7.59 | 1.02 | 0.48 | -5.34 | -2.04 | -4.26 | ||
| Changes by years, y/y, % | -66% | -113% | -53% | -1 220% | -62% | -38.1% | |||
Iovance Biotherapeutics. EV/EBITDA
Iovance Biotherapeutics. EV/EBITDA, changes, %
Iovance Biotherapeutics (IOVA) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -2.19 | -0.92 | -1.49 | -2.42 | -3.74 | -4.26 | |
| Changes by years, y/y, % | -447% | -216% | -77% | -57% | +71% | |||
| Changes by quarters, q/q, % | -61% | -58% | +62% | +62% | +55% | |||
